Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Dou, Dengfeng ^a   Park, Jewn Giew ^a   Rana, Sandeep ^a   Madden, Benjamin J ^a   Jiang, Haobo ^b   Pang, Yuan Ping ^a  

^a MAYO CLINIC   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ANTIMALARIAL AGENT; CHOLINESTERASE INHIBITOR; INSECTICIDE; PARAOXON; PROTOZOAL PROTEIN;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; HUMAN; KINETICS; MALARIA; MASS SPECTROMETRY; METABOLISM; MOSQUITO; PROTEIN BINDING;

ACETYLCHOLINESTERASE; ANIMALS; ANTIMALARIALS; CHOLINESTERASE INHIBITORS; CULICIDAE; HUMANS; INSECTICIDES; KINETICS; MALARIA; MASS SPECTROMETRY; PARAOXON; PROTEIN BINDING; PROTOZOAN PROTEINS;

MLCS; MLOWN;

EID: 84872738762     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01068     Document Type: Article

References (60)

1. Miller, L. H., Baruch, D. I., Marsh, K. & Doumbo, O. K. The pathogenic basis of malaria. Nature 415, 673-679 (2002). (Pubitemid 34136400)
2. Joy, D. A. et al. Early origin and recent expansion of Plasmodium falciparum. Science 300, 318-321 (2003). (Pubitemid 36433721)
3. Sachs, J. & Malaney, P. The economic and social burden of malaria. Nature 415, 680-685 (2002). (Pubitemid 34136401)
4. World Malaria Report 2011. http://www.who.int/malaria/world-malaria- report-2011/9789241564403-eng.pdf Accessed August 31, 2012.
5. Fialka, J. J. EPA scientists cite pressure in pesticide study. Wall Street Journal, A4 (May 25, 2006).
6. Weill, M. et al. Comparative genomics: Insecticide resistance in mosquito vectors. Nature 423, 136-137 (2003). (Pubitemid 36569529)
7. Hamer, G. L. et al.Host selection by Culex pipiens mosquitoes andWest Nile virus amplification. Am. J. Trop. Med. Hyg. 80, 268-278 (2009).
8. Sussman, J. L. et al. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253, 872-879 (1991). (Pubitemid 21917225)
9. Taylor, P. & Radic, Z. The cholinesterases: from genes to proteins. Ann. Rev. Pharmacol. 34, 281-320 (1994).
10. Raves, M. L. et al. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A. Nat. Struct. Biol. 4, 57-63 (1997). (Pubitemid 27020926)
11. Pang, Y.-P., Brimijoin, S., Ragsdale, D. W., Zhu, K. Y. & Suranyi, R. Novel and viable acetylcholinesterase target site for developing effective and environmentally safe insecticides. Curr. Drug Targets 13, 471-482 (2012).
12. Pang, Y.-P. et al. Selective and irreversible inhibitors of aphid acetylcholinesterases: steps toward human-safe insecticides. PLoS One 4, e4349 (2009).
13. Lu, Y. et al. Genome organization, phylogenies, expression patterns, and threedimensional protein models of two acetylcholinesterase genes from the red flour beetle. PLoS One 7, e32288 (2012).
14. Lu, Y. et al. Cholinergic and non-cholinergic functions of two acetylcholinesterase genes revealed by gene-silencing in Tribolium castaneum. Sci. Rep. 2, 288 (2012).
15. Pang, Y.-P. et al. Selective and irreversible inhibitors of mosquito acetylcholinesterases for controlling malaria and other mosquito-borne diseases. PLoS One 4, e6851 (2009).
16. Jennings, L. L., Malecki, M., Komives, E. A. & Taylor, P. Direct analysis of the kinetic profiles of organophosphate-acetylcholinesterase adducts by MALDI-TOF mass spectrometry. Biochemistry 42, 11083-11091 (2003). (Pubitemid 37174401)
17. Tsuge, K. & Seto, Y. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 838, 21-30 (2006). (Pubitemid 43832207)
18. Ekström, F. J., Astot, C. & Pang, Y.-P. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes. Clin. Pharmacol. Ther. 82, 282-293 (2007). (Pubitemid 47258467)
19. Carletti, E. et al.Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation. J. Am. Chem. Soc. 130, 16011-16020 (2008).
20. Dutta, S., Malla, R. K., Bandyopadhyay, S., Spilling, C. D. & Dupureur, C. M. Synthesis and kinetic analysis of some phosphonate analogs of cyclophostin as inhibitors of human acetylcholinesterase. Bioorg. Med. Chem. 18, 2265-2274 (2010).
21. Carletti, E. et al. Reaction of cresyl saligenin phosphate, the organophosphorus agent implicated in aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry, and X-ray structure analysis. Chem. Res. Toxicol. 24, 797-808 (2011).
22. Aryal, U. K. et al. Identification of phosphorylated butyrylcholinesterase in human plasma using immunoaffinity purification and mass spectrometry. Anal. Chim. Acta 723, 68-75 (2012).
23. Jiang, H., Liu, S., Zhao, P. & Pope, C. Recombinant expression and biochemical characterization of the catalytic domain of acetylcholinesterase-1 from the African malaria mosquito, Anopheles gambiae. Insect Biochem. Mol. Biol. 39, 646-653 (2009).
24. Pang, Y.-P. Novel acetylcholinesterase target site for malaria mosquito control. PLoS One 1, e58 (2006).
25. Zauhar, R. J., Colbert, C. L., Morgan, R. S. & Welsh, W. J. Evidence for a strong sulfur-aromatic interaction derived from crystallographic data. Biopolymers 53, 233-248 (2000). (Pubitemid 30082310)
26. Copeland, R. A. Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. (John Wiley & Sons, 2005).
27. Wilson, I. B., Ginsburg, S. & Quan, C. Molecular complementariness as basis for reactivation of alkyl phosphate-inhibited enzyme. Arch. Biochem. 77, 286-296 (1958).
28. Jorgensen, W. L., Chandreskhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926-935 (1982).
29. Pang, Y.-P. Three-dimensional model of a substrate-bound SARS chymotrypsinlike cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding. Proteins. 57, 747-757 (2004). (Pubitemid 39626996)
30. Pang, Y.-P. et al. Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization. Sci. Rep. 2, 257 (2012).
31. Clevenger, R. C. & Turnbull, K. D. Synthesis on N-alkylated maleimides. Synth. Commun. 30, 1379-1388 (2000). (Pubitemid 30191942)
32. Pang, Y.-P. et al. Discovery of a new inhibitor lead of adenovirus proteinase: steps toward selective, irreversible inhibitors of cysteine proteinases. FEBS Lett. 502, 93-97 (2001). (Pubitemid 32728267)
33. Olsen, J. V. et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 4, 2010-2021 (2005). (Pubitemid 41830195)
34. Mather, B. D., Viswanathan, K., Miller, K. M. & Long, T. E. Michael addition reactions in macromolecular design for emerging technologies. Prog. Polym. Sci. 31, 487-531 (2006). (Pubitemid 43737245)
35. Roepstorff, P. & Fohlman, J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 11, 601 (1984).
36. Yalcin, T., Csizmadia, I. G., Peterson, M. R. & Harrison, A. G. The structure and fragmentation of Bn (n$3) ions in peptide spectra. J. Am. Soc. Mass. Spectrom. 7, 233-242 (1996).
37. Oomens, J., Young, S., Molesworth, S.&Van Stipdonk, M. Spectroscopic evidence for an oxazolone structure of the b(2) fragment ion from protonated tri-alanine. J. Am. Soc. Mass. Spectrom. 20, 334-339 (2009).
38. Yoon, S. H. et al. IRMPD spectroscopy shows that AGG forms an oxazolone b21 ion. J. Am. Chem. Soc. 130, 17644-17645 (2008).
39. Bythell, B. J., Erlekam, U., Paizs, B. & Ma?̂tre, P. Infrared spectroscopy of fragments from doubly protonated tryptic peptides. Chem Phys Chem 10, 883-885 (2009).
40. Chen, X., Yu, L., Steill, J. D., Oomens, J. & Polfer, N. C. Effect of peptide fragment size on the propensity of cyclization in collision-induced dissociation: oligoglycine b(2)-b(8). J. Am. Chem. Soc. 131, 18272-18282 (2009).
41. Polfer, N. C., Oomens, J., Suhai, S. & Paizs, B. Spectroscopic and theoretical evidence for oxazolone ring formation in collision-induced dissociation of peptides. J. Am. Chem. Soc. 127, 17154-17155 (2005). (Pubitemid 41791013)
42. Harrison, A. G., Young, A. B., Bleiholder, C., Suhai, S. & Paizs, B. Scrambling of sequence information in collision-induced dissociation of peptides. J. Am. Chem. Soc. 128, 10364-10365 (2006). (Pubitemid 44265068)
43. Riba-Garcia, I., Giles, K., Bateman, R. H. & Gaskell, S. J. Evidence for structural variants of a-and b-type peptide fragment ions using combined ion mobility/mass spectrometry. J. Am. Soc. Mass. Spectrom. 19, 609-613 (2008).
44. Jia, C., Qi, W. & He, Z. Cyclization reaction of peptide fragment ions during multistage collisionally activated decomposition: an inducement to lose internal amino-acid residues. J. Am. Soc. Mass. Spectrom. 18, 663-678 (2007). (Pubitemid 46441875)
45. Molesworth, S., Osburn, S. & Van Stipdonk, M. Influence of size on apparent scrambling of sequence during CID of b-type ions. J. Am. Soc. Mass. Spectrom. 20, 2174-2181 (2009).
46. Harrison, A. G. Cyclization of peptide b9 ions. J. Am. Soc. Mass. Spectrom. 20, 2248-2253 (2009).
47. Erlekam, U. et al. Infrared spectroscopy of fragments of protonated peptides: direct evidence for macrocyclic structures of b5 ions. J. Am. Chem. Soc. 131, 11503-11508 (2009).
48. Wong, S. S. & Jameson, D. M. Chemistry of protein and nucleic acid cross-linking and conjugation Second edn (CRC Press, 2012).
49. Brewer, C. F. & Riehm, J. P. Evidence for possible nonspecific reactions between N-ethylmaleimide and proteins. Anal. Biochem. 18, 248-255 (1967).
50. Maurer, T. & Fung, H. L. Comparison of methods for analyzing kinetic data from mechanism-based enzyme inactivation: application to nitric oxide synthase. AAPS Pharm Sci 2, E8 (2000).
51. Kardos, S. A. & Sultatos, L. G. Interactions of the organophosphates paraoxon and methyl paraoxon with mouse brain acetylcholinesterase. Toxicol. Sci. 58, 118-126 (2000).
52. Kousba, A. A., Sultatos, L. G., Poet, T. S. & Timchalk, C. Comparison of chlorpyrifos-oxon and paraoxon acetylcholinesterase inhibition dynamics: potential role of a peripheral binding site. Toxicol. Sci. 80, 239-248 (2004). (Pubitemid 39136378)
53. Rosenfeld, C. A. & Sultatos, L. G. Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon. Toxicol. Sci. 90, 460-469 (2006).
54. Wang, C. & Murphy, S. D. Kinetic analysis of species difference in acetylcholinesterase sensitivity to organophosphate insecticides. Toxicol. Appl. Pharm. 66, 409-419 (1982). (Pubitemid 13180805)
55. Amitai, G., Moorad, D., Adani, R. & Doctor, B. P. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon. Biochem. Pharmacol. 56, 293-299 (1998). (Pubitemid 28473203)
56. Krasinski, A. et al. In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors. J. Am. Chem. Soc. 127, 6686-6692 (2005). (Pubitemid 40664175)
57. Beck, A., Heissler, D. & Duportail, G. Synthesis of fluorescent probes for localized membrane fluidity measurements. Tetrahedron 47, 1459-1472 (1991).
58. Ellman, G. L., Courtney, K. D., Andres, V. J. & Featherstone, R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88-95 (1961).
59. Lineweaver, H. & Burk, D. The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56, 658-666 (1934).
60. Gharahdaghi, F., Weinberg, C. R.,Meagher,D.A., Imai, B. S.&Mische, S. M. Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20, 601-605 (1999). (Pubitemid 29183427)